Autoimmune Hemolytic Anemia.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28189175.
- Also identified by DOI 10.1016/j.mcna.2016.09.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Autoimmune hemolytic anemia is an acquired autoimmune disorder resulting in the production of antibodies directed against red blood cell antigens causing shortened erythrocyte survival. The disorders can present as a primary disorder (idiopathic) or secondary to other autoimmune disorders, malignancies, or infections. Treatment involves immune modulation with corticosteroids and other agents.
Medical subject headings
- Anemia, Hemolytic, Autoimmune